Next-Generation Bioconjugate Therapeutics: Driving Innovation with Revolutionary Conjugation Technologies
- Overviewing GeneQuantum’s integrated conjugation and manufacturing systems, iLDC and iGDC, and applications on our advancing clinical pipelines
- Introducing the world’s first rapid ADC screening platform iDiscovery, enabling high-throughput conjugate evaluation and rapid candidate optimization
- Advancing best-in-class and first-in-class therapeutics through GeneQuantum’s next-generation conjugation technologies